Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hair Follicle | 9 | 2015 | 29 | 1.730 |
Why?
|
Epithelial Cells | 7 | 2014 | 391 | 1.050 |
Why?
|
Skin Neoplasms | 7 | 2015 | 404 | 0.960 |
Why?
|
Keratinocytes | 6 | 2015 | 63 | 0.860 |
Why?
|
Stem Cells | 7 | 2015 | 255 | 0.830 |
Why?
|
Skin | 4 | 2014 | 357 | 0.780 |
Why?
|
Adult Stem Cells | 2 | 2011 | 28 | 0.710 |
Why?
|
Tumor Suppressor Protein p53 | 6 | 2014 | 289 | 0.710 |
Why?
|
Melanoma | 3 | 2015 | 329 | 0.630 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2015 | 475 | 0.570 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 263 | 0.540 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 24 | 0.540 |
Why?
|
Biomarkers, Tumor | 8 | 2018 | 461 | 0.540 |
Why?
|
Multipotent Stem Cells | 2 | 2008 | 13 | 0.530 |
Why?
|
Exome | 1 | 2016 | 73 | 0.530 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2014 | 237 | 0.530 |
Why?
|
Precision Medicine | 2 | 2017 | 102 | 0.530 |
Why?
|
Cell Movement | 5 | 2011 | 429 | 0.530 |
Why?
|
Sebaceous Glands | 3 | 2011 | 6 | 0.520 |
Why?
|
Databases, Genetic | 1 | 2016 | 83 | 0.520 |
Why?
|
Alleles | 3 | 2016 | 411 | 0.510 |
Why?
|
Cell Differentiation | 6 | 2014 | 1304 | 0.490 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 263 | 0.480 |
Why?
|
Genome, Human | 1 | 2016 | 224 | 0.470 |
Why?
|
Ribonuclease III | 2 | 2014 | 82 | 0.460 |
Why?
|
DEAD-box RNA Helicases | 1 | 2014 | 79 | 0.440 |
Why?
|
Carcinoma, Basal Cell | 1 | 2014 | 63 | 0.440 |
Why?
|
Skin Diseases | 2 | 2011 | 76 | 0.420 |
Why?
|
Alopecia | 2 | 2011 | 25 | 0.420 |
Why?
|
Carcinogenesis | 1 | 2014 | 118 | 0.420 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2012 | 23 | 0.390 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 75 | 0.370 |
Why?
|
Telepathology | 1 | 2011 | 6 | 0.370 |
Why?
|
Melanocytes | 1 | 2012 | 78 | 0.370 |
Why?
|
Stem Cell Niche | 1 | 2011 | 13 | 0.360 |
Why?
|
Cicatrix | 1 | 2011 | 59 | 0.360 |
Why?
|
Sebaceous Gland Neoplasms | 4 | 2014 | 10 | 0.350 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 179 | 0.350 |
Why?
|
Dermatology | 1 | 2011 | 70 | 0.340 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 178 | 0.330 |
Why?
|
beta Catenin | 4 | 2015 | 86 | 0.310 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 406 | 0.300 |
Why?
|
Mice | 19 | 2017 | 10292 | 0.290 |
Why?
|
Referral and Consultation | 1 | 2011 | 398 | 0.280 |
Why?
|
Colonic Neoplasms | 4 | 2010 | 215 | 0.280 |
Why?
|
Internet | 1 | 2011 | 448 | 0.280 |
Why?
|
Humans | 39 | 2018 | 59360 | 0.260 |
Why?
|
Wound Healing | 2 | 2006 | 174 | 0.250 |
Why?
|
Animals | 21 | 2017 | 19651 | 0.240 |
Why?
|
Dermis | 1 | 2004 | 16 | 0.230 |
Why?
|
Hair | 3 | 2014 | 78 | 0.220 |
Why?
|
Cell Line, Tumor | 9 | 2015 | 1370 | 0.210 |
Why?
|
Immunohistochemistry | 8 | 2017 | 847 | 0.210 |
Why?
|
Signal Transduction | 8 | 2017 | 2902 | 0.200 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2014 | 29 | 0.190 |
Why?
|
Breast Neoplasms | 4 | 2018 | 1118 | 0.190 |
Why?
|
Materials Testing | 2 | 2012 | 82 | 0.180 |
Why?
|
Cell Proliferation | 7 | 2014 | 942 | 0.180 |
Why?
|
3T3 Cells | 3 | 2014 | 108 | 0.170 |
Why?
|
Adult | 13 | 2018 | 15669 | 0.170 |
Why?
|
Prostatic Neoplasms | 2 | 2015 | 339 | 0.170 |
Why?
|
Stem Cell Transplantation | 2 | 2011 | 75 | 0.170 |
Why?
|
T-Box Domain Proteins | 2 | 2014 | 39 | 0.170 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 234 | 0.160 |
Why?
|
Female | 20 | 2018 | 30705 | 0.160 |
Why?
|
Cell Adhesion | 2 | 2011 | 207 | 0.160 |
Why?
|
Mice, SCID | 4 | 2014 | 513 | 0.160 |
Why?
|
Mice, Inbred NOD | 4 | 2014 | 516 | 0.160 |
Why?
|
Cellular Senescence | 2 | 2011 | 104 | 0.160 |
Why?
|
Male | 17 | 2017 | 27739 | 0.150 |
Why?
|
DNA Mismatch Repair | 3 | 2014 | 31 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 411 | 0.150 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2017 | 152 | 0.150 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 26 | 0.150 |
Why?
|
Inflammation | 2 | 2017 | 1099 | 0.150 |
Why?
|
Flow Cytometry | 2 | 2011 | 644 | 0.140 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 79 | 0.140 |
Why?
|
Gene Amplification | 1 | 2017 | 23 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 394 | 0.140 |
Why?
|
Japan | 1 | 2016 | 51 | 0.140 |
Why?
|
Immunity | 1 | 2017 | 101 | 0.140 |
Why?
|
Receptor, ErbB-2 | 1 | 2017 | 51 | 0.140 |
Why?
|
Wnt Proteins | 2 | 2014 | 92 | 0.130 |
Why?
|
Autoimmunity | 1 | 2017 | 223 | 0.130 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2015 | 13 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2014 | 619 | 0.130 |
Why?
|
Mammary Glands, Animal | 2 | 2014 | 78 | 0.130 |
Why?
|
MicroRNAs | 2 | 2014 | 616 | 0.120 |
Why?
|
Middle Aged | 13 | 2018 | 16317 | 0.120 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2015 | 13 | 0.120 |
Why?
|
Neoplastic Stem Cells | 2 | 2015 | 196 | 0.120 |
Why?
|
Apoptosis | 4 | 2014 | 1032 | 0.120 |
Why?
|
Diagnosis, Differential | 4 | 2012 | 937 | 0.120 |
Why?
|
Dendritic Cells | 1 | 2017 | 515 | 0.120 |
Why?
|
DNA Damage | 2 | 2014 | 279 | 0.110 |
Why?
|
DNA-Binding Proteins | 3 | 2010 | 1151 | 0.110 |
Why?
|
Keratins | 2 | 2004 | 30 | 0.110 |
Why?
|
Fetus | 1 | 2014 | 93 | 0.110 |
Why?
|
Trans-Activators | 2 | 2007 | 300 | 0.110 |
Why?
|
Animals, Newborn | 1 | 2014 | 230 | 0.110 |
Why?
|
Transplantation, Heterologous | 5 | 2014 | 223 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 53 | 0.110 |
Why?
|
Fibroblasts | 3 | 2014 | 377 | 0.110 |
Why?
|
ras Proteins | 1 | 2014 | 77 | 0.110 |
Why?
|
Biomarkers | 3 | 2008 | 1306 | 0.110 |
Why?
|
Integrin beta4 | 2 | 2011 | 31 | 0.110 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 277 | 0.100 |
Why?
|
Breast | 1 | 2014 | 173 | 0.100 |
Why?
|
Survival Analysis | 1 | 2014 | 555 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2012 | 197 | 0.100 |
Why?
|
Mice, Transgenic | 2 | 2014 | 1206 | 0.100 |
Why?
|
Polycomb Repressive Complex 1 | 1 | 2012 | 31 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 30 | 0.100 |
Why?
|
Tetraploidy | 1 | 2012 | 2 | 0.100 |
Why?
|
Adenocarcinoma, Sebaceous | 1 | 2012 | 2 | 0.100 |
Why?
|
Melanoma-Specific Antigens | 1 | 2012 | 5 | 0.100 |
Why?
|
Nevus | 1 | 2012 | 18 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 318 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2011 | 51 | 0.100 |
Why?
|
False Positive Reactions | 1 | 2012 | 76 | 0.100 |
Why?
|
Succinimides | 1 | 2011 | 17 | 0.100 |
Why?
|
Neuropilin-2 | 1 | 2012 | 39 | 0.100 |
Why?
|
Gene Expression Profiling | 3 | 2017 | 718 | 0.100 |
Why?
|
Fluoresceins | 1 | 2011 | 29 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 17 | 0.100 |
Why?
|
Subcutaneous Tissue | 1 | 2011 | 14 | 0.100 |
Why?
|
Skin Ulcer | 1 | 2011 | 14 | 0.100 |
Why?
|
Calciphylaxis | 1 | 2011 | 17 | 0.100 |
Why?
|
Fluorouracil | 1 | 2011 | 55 | 0.090 |
Why?
|
Hemidesmosomes | 1 | 2011 | 6 | 0.090 |
Why?
|
Prognosis | 5 | 2018 | 1600 | 0.090 |
Why?
|
Cell Line, Transformed | 2 | 2008 | 98 | 0.090 |
Why?
|
Adipocytes | 1 | 2014 | 255 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2015 | 5128 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2014 | 283 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 178 | 0.090 |
Why?
|
Time-Lapse Imaging | 1 | 2011 | 18 | 0.090 |
Why?
|
Skin Aging | 1 | 2011 | 9 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2010 | 332 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 32 | 0.090 |
Why?
|
Adenoma | 2 | 2008 | 64 | 0.090 |
Why?
|
Myofibroblasts | 1 | 2010 | 15 | 0.090 |
Why?
|
Endothelium | 1 | 2010 | 18 | 0.090 |
Why?
|
Cost Savings | 1 | 2011 | 52 | 0.090 |
Why?
|
Workflow | 1 | 2011 | 63 | 0.090 |
Why?
|
Barrett Esophagus | 1 | 2010 | 30 | 0.090 |
Why?
|
Guanylate Cyclase | 1 | 2010 | 8 | 0.090 |
Why?
|
Methionine | 1 | 2010 | 53 | 0.090 |
Why?
|
Alcohol Oxidoreductases | 1 | 2010 | 27 | 0.090 |
Why?
|
Aged | 10 | 2018 | 13416 | 0.090 |
Why?
|
Receptors, Peptide | 1 | 2010 | 31 | 0.090 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 122 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 74 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 196 | 0.080 |
Why?
|
Transcriptional Activation | 2 | 2012 | 188 | 0.080 |
Why?
|
Fluorescence | 1 | 2010 | 83 | 0.080 |
Why?
|
Ischemia | 1 | 2011 | 199 | 0.080 |
Why?
|
Carcinoma | 2 | 2008 | 115 | 0.080 |
Why?
|
Sweat Gland Neoplasms | 2 | 2007 | 20 | 0.080 |
Why?
|
Up-Regulation | 2 | 2015 | 365 | 0.080 |
Why?
|
Thrombosis | 1 | 2011 | 182 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2014 | 750 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2014 | 2093 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 1093 | 0.080 |
Why?
|
fas Receptor | 1 | 2009 | 55 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2015 | 161 | 0.080 |
Why?
|
Neoplasm Staging | 3 | 2017 | 452 | 0.080 |
Why?
|
Coculture Techniques | 2 | 2009 | 95 | 0.080 |
Why?
|
Biocompatible Materials | 1 | 2010 | 141 | 0.080 |
Why?
|
Colony-Forming Units Assay | 1 | 2008 | 25 | 0.080 |
Why?
|
Cohort Studies | 2 | 2012 | 2374 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2009 | 70 | 0.080 |
Why?
|
Phenotype | 4 | 2017 | 1137 | 0.080 |
Why?
|
Mutation | 3 | 2017 | 2456 | 0.080 |
Why?
|
Epidermis | 1 | 2008 | 35 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2010 | 323 | 0.070 |
Why?
|
Mice, Knockout | 4 | 2017 | 1994 | 0.070 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2007 | 1 | 0.070 |
Why?
|
Eccrine Glands | 1 | 2007 | 3 | 0.070 |
Why?
|
Carcinoma, Ductal | 1 | 2007 | 3 | 0.070 |
Why?
|
Stromal Cells | 3 | 2014 | 65 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2008 | 96 | 0.070 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2007 | 30 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 243 | 0.070 |
Why?
|
Hypotrichosis | 1 | 2006 | 4 | 0.070 |
Why?
|
Child, Preschool | 1 | 2012 | 1782 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 148 | 0.070 |
Why?
|
Time Factors | 2 | 2011 | 3617 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2009 | 277 | 0.070 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2006 | 10 | 0.070 |
Why?
|
Diagnostic Errors | 1 | 2007 | 95 | 0.070 |
Why?
|
Lipase | 1 | 2006 | 48 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 194 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2017 | 6071 | 0.060 |
Why?
|
Integrin alpha6beta4 | 1 | 2005 | 44 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 868 | 0.060 |
Why?
|
Regeneration | 1 | 2006 | 93 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 55 | 0.060 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 234 | 0.060 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 631 | 0.060 |
Why?
|
Young Adult | 2 | 2012 | 4267 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2018 | 300 | 0.060 |
Why?
|
Prospective Studies | 1 | 2012 | 3067 | 0.060 |
Why?
|
Keratins, Type II | 1 | 2004 | 1 | 0.060 |
Why?
|
Left-Right Determination Factors | 1 | 2004 | 3 | 0.060 |
Why?
|
Keratins, Hair-Specific | 1 | 2004 | 2 | 0.060 |
Why?
|
Necrosis | 2 | 2017 | 140 | 0.060 |
Why?
|
Retroviridae | 1 | 2004 | 69 | 0.060 |
Why?
|
Cell Cycle | 1 | 2005 | 382 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 170 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 294 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 196 | 0.050 |
Why?
|
Foot Deformities, Congenital | 1 | 2002 | 2 | 0.050 |
Why?
|
Tail | 1 | 2002 | 6 | 0.050 |
Why?
|
Biopsy | 2 | 2017 | 411 | 0.050 |
Why?
|
Fetal Proteins | 1 | 2002 | 8 | 0.050 |
Why?
|
Child | 1 | 2012 | 4174 | 0.050 |
Why?
|
Fibroadenoma | 1 | 2002 | 3 | 0.050 |
Why?
|
Cystadenoma | 1 | 2002 | 6 | 0.050 |
Why?
|
Proteins | 1 | 2008 | 730 | 0.050 |
Why?
|
Abnormalities, Multiple | 1 | 2002 | 51 | 0.050 |
Why?
|
Mice, Nude | 2 | 2015 | 258 | 0.050 |
Why?
|
Eyelid Neoplasms | 1 | 2002 | 9 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 674 | 0.050 |
Why?
|
Cell Line | 3 | 2015 | 1984 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 1025 | 0.050 |
Why?
|
Adolescent | 1 | 2012 | 5824 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 857 | 0.050 |
Why?
|
Genetic Markers | 3 | 2006 | 116 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 651 | 0.040 |
Why?
|
Aging | 1 | 2006 | 710 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2010 | 3231 | 0.040 |
Why?
|
Lipid Metabolism | 2 | 2014 | 203 | 0.040 |
Why?
|
Neoplasm Grading | 1 | 2018 | 79 | 0.040 |
Why?
|
Tumor Burden | 1 | 2018 | 59 | 0.040 |
Why?
|
Lymphadenopathy | 1 | 2017 | 22 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 355 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2017 | 2050 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 1552 | 0.040 |
Why?
|
Fibrosis | 1 | 2017 | 153 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2017 | 202 | 0.030 |
Why?
|
Autoantibodies | 1 | 2017 | 172 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 188 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 188 | 0.030 |
Why?
|
Gene Deletion | 2 | 2008 | 293 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2018 | 5284 | 0.030 |
Why?
|
Dihydrotestosterone | 1 | 2015 | 17 | 0.030 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 426 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2012 | 844 | 0.030 |
Why?
|
Retinal Dehydrogenase | 1 | 2015 | 6 | 0.030 |
Why?
|
Testosterone | 1 | 2015 | 112 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 194 | 0.030 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2014 | 3 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2015 | 49 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2017 | 550 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2014 | 75 | 0.030 |
Why?
|
Wnt Signaling Pathway | 1 | 2015 | 71 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2015 | 228 | 0.030 |
Why?
|
Lentivirus | 1 | 2014 | 63 | 0.030 |
Why?
|
MutL Protein Homolog 1 | 1 | 2014 | 24 | 0.030 |
Why?
|
Collagen | 1 | 2014 | 115 | 0.030 |
Why?
|
Estrogens | 1 | 2014 | 109 | 0.030 |
Why?
|
Progesterone | 1 | 2014 | 158 | 0.030 |
Why?
|
Cytokines | 1 | 2017 | 912 | 0.030 |
Why?
|
Base Sequence | 2 | 2006 | 1302 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 396 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 55 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2010 | 850 | 0.030 |
Why?
|
Lactation | 1 | 2014 | 66 | 0.030 |
Why?
|
Ligands | 1 | 2014 | 411 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 191 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 676 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 137 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 1554 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 1952 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2010 | 1465 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2017 | 1561 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2014 | 173 | 0.020 |
Why?
|
Arterioles | 1 | 2011 | 7 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 83 | 0.020 |
Why?
|
Capillaries | 1 | 2011 | 30 | 0.020 |
Why?
|
Transcriptome | 1 | 2015 | 340 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 127 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 116 | 0.020 |
Why?
|
Basement Membrane | 1 | 2011 | 25 | 0.020 |
Why?
|
Serine | 1 | 2011 | 83 | 0.020 |
Why?
|
Drug Stability | 1 | 2011 | 141 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2011 | 287 | 0.020 |
Why?
|
Metaplasia | 1 | 2010 | 18 | 0.020 |
Why?
|
Genes, APC | 1 | 2010 | 9 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2010 | 48 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2010 | 48 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 250 | 0.020 |
Why?
|
Receptors, Guanylate Cyclase-Coupled | 1 | 2010 | 3 | 0.020 |
Why?
|
Receptors, Enterotoxin | 1 | 2010 | 3 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2010 | 32 | 0.020 |
Why?
|
Epithelium | 1 | 2010 | 96 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 65 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 244 | 0.020 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2010 | 37 | 0.020 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 45 | 0.020 |
Why?
|
Phagocytes | 1 | 2010 | 50 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 297 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 146 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 145 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 100 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2010 | 78 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2010 | 118 | 0.020 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 43 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2010 | 172 | 0.020 |
Why?
|
Bone Marrow | 1 | 2010 | 177 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2009 | 39 | 0.020 |
Why?
|
Models, Animal | 1 | 2010 | 221 | 0.020 |
Why?
|
Antigens, CD | 1 | 2010 | 343 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 527 | 0.020 |
Why?
|
RNA Interference | 1 | 2012 | 590 | 0.020 |
Why?
|
Phosphorylation | 1 | 2011 | 884 | 0.020 |
Why?
|
Back | 1 | 2008 | 4 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 450 | 0.020 |
Why?
|
Keratoacanthoma | 1 | 2008 | 2 | 0.020 |
Why?
|
Thorax | 1 | 2008 | 34 | 0.020 |
Why?
|
Cornified Envelope Proline-Rich Proteins | 1 | 2008 | 1 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 207 | 0.020 |
Why?
|
Positive Regulatory Domain I-Binding Factor 1 | 1 | 2008 | 8 | 0.020 |
Why?
|
Extremities | 1 | 2008 | 46 | 0.020 |
Why?
|
Abdomen | 1 | 2008 | 91 | 0.020 |
Why?
|
Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2007 | 4 | 0.020 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2007 | 5 | 0.020 |
Why?
|
Hepatocytes | 1 | 2009 | 196 | 0.020 |
Why?
|
Protein Precursors | 1 | 2008 | 75 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2008 | 156 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 588 | 0.020 |
Why?
|
Transfection | 1 | 2009 | 675 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 107 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 109 | 0.020 |
Why?
|
Lod Score | 1 | 2006 | 23 | 0.020 |
Why?
|
Tandem Repeat Sequences | 1 | 2006 | 26 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 12 | 0.020 |
Why?
|
Russia | 1 | 2006 | 53 | 0.020 |
Why?
|
Alu Elements | 1 | 2006 | 9 | 0.020 |
Why?
|
Cell Lineage | 1 | 2008 | 259 | 0.020 |
Why?
|
Pregnancy | 1 | 2014 | 2202 | 0.020 |
Why?
|
Retroelements | 1 | 2006 | 39 | 0.020 |
Why?
|
Homozygote | 1 | 2006 | 114 | 0.020 |
Why?
|
Pedigree | 1 | 2006 | 183 | 0.020 |
Why?
|
Heterozygote | 1 | 2006 | 161 | 0.020 |
Why?
|
Luciferases | 1 | 2006 | 106 | 0.020 |
Why?
|
Exons | 1 | 2006 | 191 | 0.020 |
Why?
|
Recurrence | 1 | 2007 | 603 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2006 | 170 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2006 | 356 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2006 | 241 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2006 | 238 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 657 | 0.010 |
Why?
|
Risk Factors | 1 | 2015 | 4984 | 0.010 |
Why?
|
Keratin-15 | 1 | 2003 | 2 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 559 | 0.010 |
Why?
|
Gene Expression | 1 | 2006 | 809 | 0.010 |
Why?
|
Syndactyly | 1 | 2002 | 1 | 0.010 |
Why?
|
Disease Progression | 1 | 2007 | 1122 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2002 | 38 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 46 | 0.010 |
Why?
|
Genes, Lethal | 1 | 2002 | 41 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2002 | 105 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2002 | 26 | 0.010 |
Why?
|
Genes, Dominant | 1 | 2002 | 55 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2002 | 49 | 0.010 |
Why?
|
Hindlimb | 1 | 2002 | 44 | 0.010 |
Why?
|
Hidrocystoma | 1 | 2002 | 1 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2002 | 29 | 0.010 |
Why?
|
Cell Division | 1 | 2003 | 443 | 0.010 |
Why?
|
Cysts | 1 | 2002 | 40 | 0.010 |
Why?
|
DNA | 1 | 2006 | 806 | 0.010 |
Why?
|
Genotype | 1 | 2002 | 617 | 0.010 |
Why?
|
Transcription Factors | 1 | 2007 | 1471 | 0.010 |
Why?
|